Nevertheless, CPC and MP treatments lower the synthesis of these pro-inflammatory cytokines and increase the synthesis of anti-inflammatory cytokines IL-10 (~8%) and IL-4 (~3%) compared to asthma-induced groups. The gene discussed is IL10; the disease is asthma.